Short Interest in Molina Healthcare, Inc. (NYSE:MOH) Declines By 16.9%

Molina Healthcare, Inc. (NYSE:MOH) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 956,100 shares, a decrease of 16.9% from the March 31st total of 1,150,000 shares. Currently, 1.7% of the company’s stock are sold short. Based on an average daily volume of 400,900 shares, the short-interest ratio is presently 2.4 days.

Molina Healthcare Price Performance

NYSE:MOH opened at $342.23 on Friday. Molina Healthcare has a 52 week low of $266.35 and a 52 week high of $423.92. The company has a quick ratio of 1.54, a current ratio of 1.49 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $20.05 billion, a PE ratio of 18.57, a price-to-earnings-growth ratio of 0.99 and a beta of 0.47. The stock’s 50-day moving average price is $390.34 and its 200-day moving average price is $371.90.

Molina Healthcare (NYSE:MOH) last posted its earnings results on Wednesday, April 24th. The company reported $5.73 EPS for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The firm had revenue of $9.93 billion for the quarter, compared to analysts’ expectations of $9.45 billion. During the same period last year, the firm earned $5.81 EPS. The company’s quarterly revenue was up 21.9% on a year-over-year basis. As a group, equities analysts expect that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. Truist Financial raised their target price on Molina Healthcare from $435.00 to $460.00 and gave the stock a “buy” rating in a research note on Tuesday, February 20th. Bank of America lowered Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price objective for the company. in a research note on Thursday, March 28th. Cantor Fitzgerald reiterated an “overweight” rating and set a $406.00 price objective on shares of Molina Healthcare in a research note on Thursday, April 4th. Wells Fargo & Company reduced their price objective on Molina Healthcare from $440.00 to $410.00 and set an “equal weight” rating for the company in a research note on Monday, April 15th. Finally, Stephens reiterated an “equal weight” rating and set a $390.00 price objective on shares of Molina Healthcare in a research note on Thursday. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $396.09.

Insider Activity

In other news, Director Richard M. Schapiro sold 711 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the sale, the director now owns 12,207 shares in the company, valued at approximately $4,688,220.42. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In related news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $386.56, for a total value of $5,798,400.00. Following the completion of the transaction, the chief financial officer now owns 36,531 shares in the company, valued at approximately $14,121,423.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Richard M. Schapiro sold 711 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $384.06, for a total value of $273,066.66. Following the completion of the transaction, the director now owns 12,207 shares of the company’s stock, valued at approximately $4,688,220.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 16,711 shares of company stock worth $6,472,517. Insiders own 1.10% of the company’s stock.

Institutional Investors Weigh In On Molina Healthcare

Several institutional investors have recently bought and sold shares of MOH. Norges Bank acquired a new stake in Molina Healthcare in the 4th quarter worth about $275,143,000. Wellington Management Group LLP boosted its holdings in Molina Healthcare by 12.8% in the 4th quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock worth $1,384,215,000 after buying an additional 436,060 shares during the last quarter. Capital Research Global Investors boosted its holdings in Molina Healthcare by 5.4% in the 4th quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock worth $878,086,000 after buying an additional 123,894 shares during the last quarter. California Public Employees Retirement System boosted its holdings in Molina Healthcare by 53.0% in the 3rd quarter. California Public Employees Retirement System now owns 331,652 shares of the company’s stock worth $108,745,000 after buying an additional 114,890 shares during the last quarter. Finally, Invesco Ltd. boosted its holdings in Molina Healthcare by 10.4% in the 3rd quarter. Invesco Ltd. now owns 1,190,161 shares of the company’s stock worth $390,242,000 after buying an additional 112,243 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.